Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Sadif Analytics Prime
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biosensors International Group and Terumo Corp extend licensing agreements

Wednesday, 2 Apr 2014 05:21am EDT 

Biosensors International Group Ltd:Extends their existing licensing agreements and an expansion of their sales collaboration in Japan, with regard to Terumo‚Äôs Nobori drug-eluting stent with Terumo Corporation.Under the terms Terumo will continue to incorporate BioMatrix technology in the production, marketing and sales of the Nobori drug-eluting stent in territories outside of Japan, excluding the United States, until Dec. 2016. 

Company Quote

28.0 +1.00%
23 Jan 2015